These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17310216)

  • 1. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.
    Yu C; Zhang X; Huang Q; Klein M; Goyal RK
    Lab Invest; 2007 May; 87(5):466-72. PubMed ID: 17310216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions.
    Zhang X; Huang Q; Goyal RK; Odze RD
    Am J Surg Pathol; 2008 Sep; 32(9):1327-35. PubMed ID: 18670357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium.
    Liu W; Hahn H; Odze RD; Goyal RK
    Am J Gastroenterol; 2009 Apr; 104(4):816-24. PubMed ID: 19293780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
    Fang M; Lew E; Klein M; Sebo T; Su Y; Goyal R
    Am J Gastroenterol; 2004 Oct; 99(10):1887-94. PubMed ID: 15447746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue.
    Giménez A; Minguela A; de Haro LM; Parrilla P; Bermejo J; Pérez D; García AM; Ortiz MA; Molina J; Alvarez R
    World J Surg; 2000 Jan; 24(1):72-7. PubMed ID: 10594207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
    Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
    Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression to cancer in Barrett's esophagus is associated with genomic instability.
    Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
    Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus.
    Khan M; Bui HX; del Rosario A; Abdulla M; Ballouk F; Sim YJ; Ross JS
    Mod Pathol; 1994 Feb; 7(2):169-74. PubMed ID: 8008738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma.
    Huang Q; Yu C; Zhang X; Goyal RK
    BMC Clin Pathol; 2008 May; 8():5. PubMed ID: 18513411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
    Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
    Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.
    Reid BJ; Blount PL; Rubin CE; Levine DS; Haggitt RC; Rabinovitch PS
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1212-9. PubMed ID: 1551528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.
    Snider EJ; Compres G; Freedberg DE; Khiabanian H; Nobel YR; Stump S; Uhlemann AC; Lightdale CJ; Abrams JA
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1687-1693. PubMed ID: 31466948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia.
    Younes M; Lechago J; Chakraborty S; Ostrowski M; Bridges M; Meriano F; Solcher D; Barroso A; Whitman D; Schwartz J; Johnson C; Schmulen AC; Verm R; Balsaver A; Carlson N; Ertant A
    Scand J Gastroenterol; 2000 Feb; 35(2):131-7. PubMed ID: 10720109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.
    Doak SH; Jenkins GJ; Parry EM; D'Souza FR; Griffiths AP; Toffazal N; Shah V; Baxter JN; Parry JM
    Gut; 2003 May; 52(5):623-8. PubMed ID: 12692043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.
    Beilstein M; Silberg D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.
    Fassan M; Pizzi M; Battaglia G; Giacomelli L; Parente P; Bocus P; Ancona E; Rugge M
    J Clin Pathol; 2010 Aug; 63(8):692-6. PubMed ID: 20702469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.